ici 118551 has been researched along with carvedilol in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, JG | 1 |
Abuin, L; Cotecchia, S; Lattion, A; Nenniger-Tosato, M | 1 |
Bond, RA; Callaerts-Vegh, Z; Evans, KL; Liu, X | 1 |
Bond, RA; Callaerts-Vegh, Z; Cuba, DL; Davies, PJ; Evans, KL; Giles, H; Gurji, HA; Shipley, GL | 1 |
Harada, N; Isobe, H; Okajima, K; Uchiba, M | 1 |
Christ, T; Kaumann, A; Molenaar, P; Ravens, U | 1 |
Abe, H; Anson, BD; Delisle, BP; January, CT; Kawakami, K; Kikuchi, K; Nagatomo, T; Nakashima, Y; Takemasa, H | 1 |
Coelho, M; Correia, G; Medeiros, R; Moz, M; Ribeiro, L; Teixeira, A | 1 |
Maniak, PJ; O'Grady, SM; Peitzman, ER; Zaidman, NA | 1 |
Benovic, JL; Carr, R; Carter, RL; Cheung, JY; Du, Y; Koch, WJ; Schilling, J; Song, J; Tilley, DG; Traynham, CJ; Yoo, SM | 1 |
Du, XJ; Hu, HY; Kiriazis, H; Lu, Q; Nguyen, MN; Puthalakath, H; Sadoshima, J; Su, Y; Wang, LN; Zhao, WB; Ziemann, M | 1 |
11 other study(ies) available for ici 118551 and carvedilol
Article | Year |
---|---|
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Constitutively active mutants of the beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amino Acid Substitution; Betaxolol; Carbazoles; Carvedilol; Cell Line; Cyclic AMP; Epinephrine; Humans; Imidazoles; Isoproterenol; Labetalol; Point Mutation; Practolol; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Proteins; Timolol | 1999 |
Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Carbazoles; Carvedilol; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Humans; Infusion Pumps, Implantable; Mice; Mice, Transgenic; Myocardium; Propanolamines; Receptors, Adrenergic, beta-2 | 2002 |
Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Carbazoles; Carvedilol; Coronary Disease; Coronary Vessels; Ligands; Male; Mice; Mice, Inbred C57BL; Propanolamines; Receptors, Adrenergic, beta | 2003 |
Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bisoprolol; Blood Pressure; Calcitonin Gene-Related Peptide; Capsaicin; Carbazoles; Carvedilol; Cells, Cultured; Drug Interactions; Female; Humans; Hypertension; Kidney; Male; Mice; Neurons, Afferent; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Regional Blood Flow | 2004 |
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
Topics: Adrenergic beta-Antagonists; Calcium Channels, L-Type; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Epinephrine; Heart Atria; Heart Failure; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Metoprolol; Myocardial Contraction; Myocardium; Norepinephrine; Patch-Clamp Techniques; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2006 |
Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
Topics: Adrenergic beta-Antagonists; Binding Sites; Carbazoles; Cardiovascular Diseases; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Long QT Syndrome; Membrane Potentials; Metoprolol; Mutation; Potassium Channel Blockers; Propanolamines; Propranolol; Protein Binding; Transfection | 2006 |
Antiproliferative effects of β-blockers on human colorectal cancer cells.
Topics: Adenocarcinoma; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Carbazoles; Carvedilol; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Epinephrine; HT29 Cells; Humans; Isoproterenol; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Signal Transduction | 2015 |
Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells.
Topics: Adrenergic beta-Antagonists; Anions; Arrestins; beta-Arrestins; Carbazoles; Carvedilol; Cells, Cultured; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Propanolamines; Receptors, Adrenergic, beta-2; Signal Transduction | 2016 |
β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
Topics: Adrenergic beta-Antagonists; Animals; beta-Arrestins; Carbazoles; Carvedilol; Cell Line, Tumor; Drug Evaluation, Preclinical; Heart Failure; HEK293 Cells; Humans; Lipopeptides; Mice; Myocardial Contraction; Myocytes, Cardiac; Primary Cell Culture; Propanolamines; Protein Conformation | 2016 |
Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bcl-2-Like Protein 11; Cardiovascular Diseases; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Galectin 3; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta-3; Signal Transduction; Up-Regulation | 2019 |